Tuesday, September 27, 2011
New Clinical Trial
We started the new clinical trial last month. It is a stage III trial sponsored by Knopp pharmaceuticals and Biogen. It is a global stud involving more than 800 participants. It is testing the effectiveness of dexpramipexole on slowing ALS disease progression. It is a 12 month study, so cross your fingers crossed…
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment